Wenxin Wang
 | The topic of this article may not meet Wikitia's general notability guideline. |
Wenxin Wang | |
|---|---|
| Alma mater | Sichuan University (BSc); Shanghai Jiao Tong University (MSc, PhD) |
| Known for | Polymer chemistry, biomaterials, non-viral gene therapy, wound healing |
| Awards | NovaUCD Innovation Award (2025) Science Foundation Ireland Principal Investigator Award (2011) TERMIS-EU Young Scientist Prize (2010) Fellow of the Royal Society of Chemistry |
| Scientific career | |
| Fields | Materials science, biomedical engineering, dermatology |
| Institutions | University College Dublin |
Wenxin Wang is a Chinese-born materials scientist and polymer chemist based in Ireland. He is a professor at the Charles Institute of Dermatology, University College Dublin (UCD), and a Science Foundation Ireland Principal Investigator.[1] Wang is recognised for developing controlled polymerisation techniques for multivinyl monomers and for pioneering non-viral gene-therapy strategies to treat the rare skin disease recessive dystrophic epidermolysis bullosa (RDEB). His research has been covered in national and scientific media including The Irish Times, The Times,[2] Irish Independent, The Journal,[3] and Irish Medical Times,
Career
Wang received a B.Sc. in polymer science from Sichuan University in 1990 and an M.Sc. (1996) and Ph.D. (1999) in polymer materials from Shanghai Jiao Tong University. He conducted post-doctoral research at the Centre for Education and Research on Macromolecules (CERM) at the University of Liège in Belgium and later at the University of Nottingham, working in green chemistry and biomaterials.[4]
He joined the National University of Ireland, Galway in 2008 as a lecturer and moved to UCD in 2013, becoming full professor in 2018.[5]Since 2009 he has graduated 27 PhD students and mentored over 29 postdoctoral researchers, and he has published over 280 papers in leading journals such as Nature Communications, Angewandte Chemie, Science Advances, and Nature Reviews Chemistry.[6] Wang’s publications have been cited in more than 24,000 scholarly papers,[7] and he is a Fellow of the Royal Society of Chemistry.
Research
Wang’s research combines polymer chemistry, biomaterials, and gene therapy, with applications in regenerative medicine and skin repair. His work has been reported by national media including The Irish Times, The Times, Irish Independent, and Irish Medical Times for its relevance to polymer chemistry and novel therapies for epidermolysis bullosa.[8][2][9]
Polymer chemistry
Wang’s early work focused on the design and control of polymer architectures. He introduced the concept of deactivation-enhanced atom transfer radical polymerisation (DE-ATRP), a strategy that enabled controlled polymerisation of multivinyl monomers (MVMs), overcoming gelation limitations described by the Flory–Stockmayer theory.[10] This approach made possible the synthesis of single-chain cyclic and knotted polymers, later published in Nature Communications and Angewandte Chemie.[11] The work was described in chemistry world as a “Celtic-knot” inspired polymer design.[12] He has since published widely on controlled polymerisation and complex macromolecular structures in journals such as Nature Reviews Chemistry and Journal of the American Chemical Society.
Non-viral gene delivery and epidermolysis bullosa
Wang’s laboratory develops non-viral polymeric vectors for gene delivery. His group designed hyperbranched poly(β-amino ester)s (HPAEs) to improve gene-transfer efficiency and biocompatibility.[13] Using this platform, his team pursued gene-therapy approaches for the inherited skin disorder recessive dystrophic epidermolysis bullosa (RDEB). This research was covered extensively in Irish media in 2019 and 2021, which described the work as a potential treatment for the “butterfly skin” disease.[14][3][9]
Entrepreneurship
In addition to his academic work, Wang has been involved in translating laboratory research into commercial applications in biomaterials and gene therapy.
He founded Vornia Ltd., a spin-out company from University College Dublin that specialised in biodegradable polymers and medical-grade materials. In 2018, The Times reported that Vornia was acquired by the US-based multinational Ashland, which integrated the company’s biodegradable polymer technology into its speciality ingredients division.[15]
Wang also co-founded Blafar Ltd., which develops functionalised biopolymers for research and medical-device applications,[16] and Branca Bunús Ltd., a biotechnology start-up working on non-viral gene therapies for rare skin disorders such as epidermolysis bullosa.[17]
Honours and awards
Wang has received several academic and research distinctions over his career.
- NovaUCD Innovation Award (2025): Presented by University College Dublin in recognition of his contributions to translational skin research and entrepreneurship.[18]
- Science Foundation Ireland Principal Investigator Award (2011): Granted by Science Foundation Ireland to support independent research leadership in functional biomaterials.
- TERMIS-EU Young Scientist Prize in Regenerative Medicine (2010): Awarded by the Tissue Engineering and Regenerative Medicine International Society (European Chapter) for his work in biomaterials and regenerative medicine.[19]
- Fellow of the Royal Society of Chemistry (FRSC): Elected Fellow for contributions to polymer chemistry and biomedical materials science.
In addition to academic recognition, his work on epidermolysis bullosa therapy has been covered by multiple independent news outlets, including The Irish Times, The Times, and Irish Independent, for its clinical potential.[14]
References
- ↑ "Wenxin Wang – Faculty Profile". University College Dublin. Retrieved 6 October 2025.
- ↑ 2.0 2.1 "Gene therapy offers hope of breakthrough for skin disease". The Times. 21 October 2019. Retrieved 6 October 2025.
- ↑ 3.0 3.1 "UCD researchers developing "life-changing" treatment for painful skin condition". The Journal. 6 July 2021. Retrieved 6 October 2025.
- ↑ "Former Group Members". University of Nottingham. Retrieved 6 October 2025.
- ↑ "Wenxin Wang – Faculty Profile". University College Dublin. Retrieved 6 October 2025.
- ↑ "Scopus Author Profile: Wenxin Wang". Elsevier.
- ↑ "Google Scholar profile of Wenxin Wang". Google Scholar. Retrieved 2025-01-14.
- ↑ "Research riches: what we get for our money". The Irish Times. 26 Jun 2014.
- ↑ 9.0 9.1 "Irish researchers target gene-editing therapy as potential EB treatment". Irish Medical Times. 8 May 2025. Retrieved 6 October 2025.
- ↑ Wang, W.; Zheng, Y.; Roberts, E.; Duxbury, C. J.; Ding, L.; Irvine, D. J.; Howdle, S. M. (2007). "Controlling chain growth: a new strategy to hyperbranched materials". Macromolecules. 40 (20): 7184–7194. Bibcode:2007MaMol..40.7184W. doi:10.1021/ma0707133.
- ↑ Zhao, T.; Zheng, Y.; Poly, J.; Wang, W. (2013). "Controlled multi-vinyl monomer homopolymerization through vinyl oligomer combination as a universal approach to hyperbranched architectures". Nature Communications. 4 1873. Bibcode:2013NatCo...4.1873Z. doi:10.1038/ncomms2887. PMID 23695667.
- ↑ "Ancient Celtic Knots inspire scientific breakthrough". chemistry world. 28 May 2013. Retrieved 14 January 2026.
- ↑ Zhou, D.; Cutlar, L.; Gao, Y.; Wang, W. (2016). "The transition from linear to highly branched poly(β-amino ester)s: branching matters for gene delivery". Science Advances. 2 (6) e1600102. Bibcode:2016SciA....2E0102Z. doi:10.1126/sciadv.1600102. PMC 4928911. PMID 27386572.
- ↑ 14.0 14.1 "Breakthrough by UCD experts seeking cure for rare "butterfly" skin disease". Irish Independent. 21 October 2019. Retrieved 6 October 2025.
- ↑ "Ashland has skin in the game with UCD dermatology research". The Times. 17 February 2019. Retrieved 6 October 2025.
- ↑ "Blafar LTD – New state of the art quality management system". Irish Tech News. 13 August 2020. Retrieved 6 October 2025.
- ↑ "Duoning and Branca Bunús Collaborate on Gene Delivery Technology". Contract Pharma. 6 November 2024. Retrieved 6 October 2025.
- ↑ "Skin and wound-healing research expert and entrepreneur receives 2025 NovaUCD Innovation Award". UCD News. 11 April 2025. Retrieved 6 October 2025.
- ↑ "TERMIS-EU Young Scientist Prize in Regenerative Medicine 2010 – Award Announcement". DEBRA Ireland. Retrieved 6 October 2025.
External links
This article "Wenxin Wang" is from Wikipedia. The list of its authors can be seen in its historical. Articles taken from Draft Namespace on Wikipedia could be accessed on Wikipedia's Draft Namespace.